Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis

Autor: Wetzel, Lisa A., Hurtado, Myrna, MacDowell Kaswan, Zoe A., McCusker, Robert H., Steelman, Andrew J.
Zdroj: In Brain, Behavior, & Immunity - Health August 2020 7
Databáze: ScienceDirect